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Abstract
Background: DNA methylation outlier burden has been suggested as a potential marker of biological age. An
outlier is typically defined as DNA methylation levels at any one CpG site that are three times beyond the inter-
quartile range from the 25th or 75th percentiles compared to the rest of the population. DNA methylation outlier
burden (the number of such outlier sites per individual) increases exponentially with age. However, these findings
have been observed in small samples.
Results: Here, we showed an association between age and log10-transformed DNA methylation outlier burden in a
large cross-sectional cohort, the Generation Scotland Family Health Study (N = 7010, β = 0.0091, p < 2 × 10−16), and
in two longitudinal cohort studies, the Lothian Birth Cohorts of 1921 (N = 430, β = 0.033, p = 7.9 × 10−4) and 1936
(N = 898, β = 0.0079, p = 0.074). Significant confounders of both cross-sectional and longitudinal associations
between outlier burden and age included white blood cell proportions, body mass index (BMI), smoking, and batch
effects. In Generation Scotland, the increase in epigenetic outlier burden with age was not purely an artefact of an
increase in DNA methylation level variability with age (epigenetic drift). Log10-transformed DNA methylation outlier
burden in Generation Scotland was not related to self-reported, or family history of, age-related diseases, and it was
not heritable (SNP-based heritability of 4.4%, p = 0.18). Finally, DNA methylation outlier burden was not significantly
related to survival in either of the Lothian Birth Cohorts individually or in the meta-analysis after correction for
multiple testing (HRmeta = 1.12; 95% CImeta = [1.02; 1.21]; pmeta = 0.021).
Conclusions: These findings suggest that, while it does not associate with ageing-related health outcomes, DNA
methylation outlier burden does track chronological ageing and may also relate to survival. DNA methylation
outlier burden may thus be useful as a marker of biological ageing.
Keywords: Ageing, Epigenetics, Stochastic epigenetic mutations, Epigenetic outliers, Survival, Generation Scotland,
Lothian Birth Cohorts
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Background
Chronological age is a major risk factor for many dis-
eases. Consequently, as life expectancy increases, so too
does the prevalence of age-related diseases. However,
there are considerable inter-individual differences in
health outcomes [1]. In order to improve risk stratifica-
tion beyond crude models based on chronological age,
much recent work has thus attempted to identify and
test the utility of markers of ‘biological age’.
One focus of research into ageing biomarkers has been
on age-related changes in DNA methylation at cytosine-
phosphate-guanine (CpG) dinucleotide sites. DNA methy-
lation is a dynamic epigenetic modification that is involved
in the regulation of gene expression and is influenced by
both genetics [2] and the environment [3]. Analyses have
identified a number of loci where methylation changes
consistently across individuals as they age, for example the
cg16867657 locus in the ELOVL2 gene [4]. In addition to
such sites, methylation levels at other loci have been
shown to diverge as individuals grow older [5]. This is
consistent with the observation that, on average, inter-
individual variability in DNA methylation tends to in-
crease as people get older, a phenomenon referred to as
epigenetic drift [5, 6].
Recently, researchers have started to investigate the ac-
cumulation of DNA methylation outliers (sometimes re-
ferred to as ‘stochastic epigenetic mutations’). DNA
methylation outliers occur when the DNA methylation
level at a specific site in an individual’s genome differs
greatly from that of the majority of the population at this
locus. It is known that abnormal methylation patterns
can lead to aberrant gene expression, and DNA methyla-
tion outliers have been shown to be associated with the
development of certain cancers [7, 8] or neurodevelop-
mental disorders and congenital anomalies [9].
In addition, many studies have investigated the dysreg-
ulation of biological processes with age. This includes in-
nate immune system function [10] but also epigenetic
processes such as DNA methylation [11]. DNA methyla-
tion outlier burden (i.e. the number of outlier sites per
individual), as a novel measure of such dysregulation,
may thus also have predictive value as an index of bio-
logical ageing.
Indeed, Gentilini and colleagues [12] found an expo-
nential association between age and DNA methylation
outlier burden in 170 individuals aged between 3 and
106 years (rlog (outlier burden) – age = 0.63). The authors de-
fined outliers as methylation levels of greater than 3
times the inter-quartile range (IQR) from the 25th and
75th percentiles compared to the rest of the population.
More recently, two further studies replicated this finding
using data from 658 individuals of a wide age range
(mean = 54.3 years, SD = 12.7 years) and longitudinal
data from 375 older individuals (48 to 98 years),
respectively [13, 14]. Both studies reported individual
outlier burden to be highly variable (range 119–18,308
out of 769,042 CpGs [14]; range 58–26,291 out of 370,
234 CpGs [13]) and non-normally distributed. Following
log-transformation, these studies found outlier burden
to be higher in older individuals (z = 8.54; p = 1.2 ×
10−17 [14]; β = 8.3 × 10−3, p = 1.2 × 10−13 [13]). In
addition, white blood cell proportions were found to be
significantly associated with outlier burden in both
studies.
Here, we provide a comprehensive characterisation of
DNA methylation outlier burden in a large cross-sectional
sample of 7010 individuals and in two longitudinal sam-
ples of 430 and 898 individuals, respectively. We investi-
gate the association of DNA methylation outlier burden
with age, explore the potential confounding effect of epi-
genetic drift on these findings, relate outlier burden to
more than a dozen health- and ageing-related traits and to
survival, and determine the genetic contribution to indi-
vidual differences in outlier burden.
Results
Descriptive statistics
Descriptive statistics for age, sex, and outlier burden in
the three cohorts are shown in Table 1 (for more de-
tailed descriptive statistics including covariate informa-
tion, see Supplementary Tables 1A, 1B and 1C,
Additional file 1).
In Generation Scotland, the mean number of outliers
per individual was 1119 (SD = 3361) and highly variable,
ranging from 53 to 84,933 (out of 334,352 and 349,027
CpG sites in set 1 and set 2, respectively). The distribution
of outlier number per individual was positively skewed,
even after log10 transformation. In the combined Gener-
ation Scotland dataset, 97% of 361,846 CpG sites had at
least one individual with a DNA methylation outlier at
present. On average, CpG sites had 22 individuals with
DNA methylation outliers at the site (SD = 33, max =
1587, across 7010 individuals). In the Lothian Birth Co-
hort 1921 (LBC1921) and in the Lothian Birth Cohort
1936 (LBC1936) at wave 1, there were on average 2039
(min = 108; max = 27,676; SD = 3280) and 2197 (min =
119; max = 35,711; SD = 3203) DNA methylation outliers
per individual (out of 356,631 CpG sites), respectively.
The distribution of outlier number per individual was
positively skewed. Following log10 transformation, the dis-
tribution looked approximately normal. Sixty-three per-
cent of 356,631 CpG sites were found to have at least one
individual with an outlier present in the LBC1921 at wave
1 (83% in the LBC1936). On average, CpG sites had three
individuals with outliers at this site (SD = 5, max = 108,
across 430 individuals) in the LBC1921 and six individuals
with outliers at this site (SD = 10, max = 225, across 898
individuals) in the LBC1936.
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DNA methylation outlier burden and age
In Generation Scotland, there was a small but significant
cross-sectional association between age and log10(outlier
burden) in all models regardless of adjustments (Supple-
mentary Table 2, Additional file 1) (β = 0.0091 increase
in burden per year, p < 2 × 10−16, fully adjusted model;
this corresponded to a 2.1% higher outlier burden per
year older in age). The association between log10(outlier
burden) and age was non-linear (Fig. 1). There was
evidence of heteroscedasticity in the model residuals
(Supplementary Figure 1, Additional file 2).
A number of covariates included in the fully adjusted
model were significantly associated with DNA methylation
outlier burden (Supplementary Table 3A, Additional file 1).
B cell, natural killer (NK), CD8+ T cell, and granulocyte
proportions were positively associated with outlier burden
(βraw = 0.15, p < 2 × 10
−16; β = 0.075, p = 6.6 × 10−10; β =
0.084, p = 2.2 × 10−16; and β = 0.045, p = 0.026; coefficients
refer to a unit change in log10(outlier burden) per standard
deviation change in the predictor). The proportion of
CD4+ T cells was negatively associated with outlier burden
(β = − 0.078, p = 4.5 × 10−9). Log10(pack years + 1) was posi-
tively associated and log10(BMI) was negatively associated
with outlier burden (β = 0.025, p = 4.3 × 10−3; β = − 0.013,
p = 8.0 × 10−3). Sex, never vs. ever smoking status, and can-
cer were not significantly associated with outlier burden.
Longitudinally, and prior to adjustments, DNA methy-
lation outlier burden increased with age in LBC1921 and
decreased with age in the LBC1936 (Fig. 1; Fig. 2).
However, after adjustment for covariates, the association be-
tween age and log10(outlier burden) was positive in both co-
horts (Fig. 1). This association was significant after
adjustment for cell counts in the LBC1921 (β = 0.033,
p = 7.9 × 10−4, fully adjusted model; this corresponded to a
7.9% increase in outlier burden per year increase in age) but
not in the LBC1936 (β = 7.9 × 10−3, p = 0.074, fully adjusted
model; 1.8% increase per year) (Supplementary Table 2,
Additional file 1). Ageing trajectories for those individuals
with complete observations, i.e. observations in all waves
(63 in the LBC1921 and 337 in the LBC1936), were similar
to those observed in the entire sample (Supplementary
Figures 2, 3, and 4, Additional file 2).
As in Generation Scotland, estimated cell proportions
of B cells, NK cells, and CD8+ T cells in the LBC1921
(β = 0.20, p < 2 × 10−16; β = 0.13, p = 6.7 × 10−6; β = 0.082,
p = 2.8 × 10−3) and B cells, NK cells, and CD4+T cells in
the LBC1936 were significantly related to outlier burden
(β = 0.13, p < 2 × 10−16; β = 0.056, p = 1.0 × 10−4;
β = − 0.059, p = 1.1 × 10−3). No other covariates were sig-
nificantly associated with DNA methylation outlier burden
in either the LBC1921 or the LBC1936 (Supplementary
Table 3B and 3C, Additional file 1).
The relationship between outlier burden and three
measures of epigenetic age acceleration was examined in
Generation Scotland and the Lothian Birth Cohorts:
Hannum age acceleration, GrimAge acceleration, and in-
trinsic epigenetic age acceleration (IEAA) [15–17]. A sig-
nificant positive association was observed between
Table 1 Descriptive statistics
Generation Scotland
N 7010 – – –
Females 4076 (58%) – – –
Mean age 51 (13) – – –
Outlier burden 1119 (3361) – – –
LBC1921
Wave 1 Wave 2 Wave 3 Wave 4
N 430 – 173 82
Females 260 (60%) – 94 (54%) 44 (54%)
Mean age 79 (0.58) – 87 (0.40) 90 (0.10)
Outlier burden 2039 (3280) – 2330 (3901) 1717 (2029)
LBC1936
Wave 1 Wave 2 Wave 3 Wave 4
N 898 793 607 502
Females 445 (50%) 376 (47%) 291 (48%) 249 (50%)
Mean age 70 (0.83) 73 (0.70) 76 (0.67) 79 (0.62)
Outlier burden 2197 (3203) 2729 (6020) 2293 (6861) 1423 (2845)
Sample numbers (N) alongside their proportion in the entire sample (in %) are reported for categorical variables. Mean (M) and standard deviation (SD) values are
reported for continuous variables
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outlier burden and both Hannum and GrimAge acceleration
in LBC1921 after adjusting for sex and estimated cell propor-
tions (βGrimAge = 3.52, p = 2.6 × 10
−8; βHannum = 5.51, p = 2.8
× 10−10). Similarly in Generation Scotland, a significant rela-
tionship was observed between Hannum and GrimAge ac-
celeration, as well as IEAA (βGrimAge = 1.59, p = 2.9 × 10
−42;
βHannum = 1.32, p = 3.1 × 10
−52; βIEAA = 0.7, p = 1.5 × 10
−52;
Supplementary Table 4A, Additional file 1). DNA methyla-
tion outlier counts were compared between published con-
stituent clock CpGs (Horvath and Hannum clocks) and non-
clock CpGs in Generation Scotland and both LBC cohorts.
Hannum clock probes had a lower average outlier count
compared to non-clock probes in all cohorts. In Generation
Scotland, the average outlier count for Horvath clock probes
was significantly greater than that of non-clock probes
(meanHorvathClock = 27.2, meanNonClock = 21.7; p = 0.002).
There were no significant differences in outlier counts
between Horvath clock CpGs and non-clock CpGs in
the remaining cohorts (Supplementary Table 4B, Add-
itional file 1).
DNA methylation outlier burden and epigenetic drift
In Generation Scotland, DNA methylation outlier bur-
den based on an alternative definition of outliers within
age groups correlated almost perfectly with outlier
burden calculated using the original definition (r = 0.99,
p < 2 × 10−16). Accounting for epigenetic drift by apply-
ing the alternative definition for outliers slightly attenu-
ated the association between DNA methylation outlier
burden and age in Generation Scotland (Supplementary
Table 5A, Additional file 1) (β = 6.2 × 10−3, p < 10−16,
fully adjusted model; corresponding to a 1.4% higher
DNA methylation outlier burden per year older in age).
However, the association was still highly significant and
the pattern of covariate associations did not change
(effect sizes for each covariate presented in Supplementary
Table 5B, Additional file 1).
DNA methylation outlier burden, health, and survival
We did not find evidence for a cross-sectional associ-
ation between DNA methylation outlier burden and self-
Fig. 1 DNA methylation outlier burden in Generation Scotland, LBC1921, and LBC1936. Distribution of log10(outlier burden) in Generation Scotland
(black, blue contour shapes indicating data density) and in the four LBC1936 waves (orange) and three LBC1921 waves (yellow). a Linear regression
lines in Generation Scotland (blue) and in the LBC1921 and LBC1936 (red) to model the association of log10(Outlier Burden) ~ age. b Fitted values for
the regression of log10(outlier burden) ~ age with random factor batch and cell proportions fit to the mean
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reported disease (Supplementary Tables 6A and 6B, Add-
itional file 1) or family history of disease (Supplementary
Tables 7A and 7B, Additional file 1) in Generation
Scotland following Bonferroni correction.
DNA methylation outlier burden was not significantly
associated with survival in the LBC1921 or the LBC1936
individually (Fig. 3; Supplementary Table 8, Additional file
1). However, when meta-analysed across the two cohorts,
the association between outlier burden and survival was
significant at a nominal p < 0.05 threshold (hazard ratio-
meta = 1.12; 95% CImeta = [1.02; 1.21]; pmeta = 0.021).
Heritability of DNA methylation outlier burden
There was no significant genetic contribution by all com-
mon genome-wide SNPs (minor allele frequency > 5%) to
phenotypic variability in log10-transformed DNA methyla-
tion outlier burden (h2 = 0.044, SE = 0.048, p = 0.18).
Directionality of DNA methylation outliers
Directionality of DNA methylation outliers was assessed
in Generation Scotland and baseline Lothian Birth
Cohort samples. Hypermethylated outliers were defined
as DNA methylation outliers that were greater than
three times the IQR above the upper quartile of a given
CpG, whereas hypomethylated outliers were defined as
those that were less than three times the IQR below the
lower quartile. There were 69,298 hypermethylated out-
lier probes common to all cohorts, and 61,578 hypo-
methylated outlier probes. There was a significant
difference in the distribution of hyper- and hypomethy-
lated outliers across CpG islands, shores, shelves, and
open seas (χ2 = 46,944; p < 2.2 × 10−16). Hypermethy-
lated outlier CpGs were predominantly located at CpG
islands, whereas the majority of hypomethylated outlier
sites mapped to open seas (Supplementary Table 9, Add-
itional file 1).
Identification of common DNA methylation outliers
We investigated the presence of common DNA outliers
between cohorts, comparing common outliers (i.e. those
present in at least 5% of Generation Scotland individuals;
N ≥ 351 participants) to rare outliers (present in < 5% of
Fig. 2 Trajectories of DNA methylation outlier burden in the LBC1921 and LBC1936. Longitudinal change in log10(outlier burden) in individuals in
the LBC1921 and the LBC1936. The linear regression lines of log10(Outlier Burden) ~ age are shown in red
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Generation Scotland individuals). Of 208 common out-
lier CpGs in Generation Scotland, data for 187 were
available for the LBC cohorts. The proportion of individ-
uals with ‘common’ outliers in the LBC studies was sig-
nificantly greater than the proportion of individuals with
‘rare’ outliers (as defined in Generation Scotland; p ≤
3.64 × 10−22; Supplementary Table 10A, Additional file
1). The distribution of common outliers across CpG
islands, shelves, shores, and open seas was significantly
different to that of rare outliers (χ2 = 82.58; p = 2.42 ×
10−16; Supplementary Table 10B, Additional file 1).
Identification of outlier individuals
Eight outlier individuals were identified in Generation
Scotland set 2, all of whom had an excess of DNA
methylation outliers. Outlier individuals were defined as
those having an outlier burden ± 3 interquartile ranges
from the upper/lower quartile of outlier counts in the
study population. No outlier individuals were identified
in Generation Scotland set 1 or at any wave of the Lo-
thian Birth Cohorts. Two outlier CpG sites were com-
mon to the eight outlier individuals (cg05941108 and
cg02279719). While outlier individuals were older than
non-outlier individuals on average, this difference was
not significant, suggesting the excess of outliers in these
individuals is not age-related (meanoutlier = 57.0 years,
SDoutlier = 15.8; meannon-outlier = 51.3 years, SDnon-outlier
= 13.2; p = 0.34).
Discussion
Here, we characterised DNA methylation outlier burden,
which has been suggested as a promising new marker of
biological age, in three large cohorts: the cross-sectional
Generation Scotland cohort of individuals aged 18 to 92
years and the Lothian Birth Cohorts of 1921 and 1936,
which are longitudinal studies of older adults aged, on
average, 79 and 69 years at baseline, respectively. We ana-
lysed methylation levels at those sites present on the Illu-
mina Infinium HumanMethylation450k array, to permit
comparison with findings by Wang and colleagues [13] in
the Swedish Adoption/Twin Study of Aging (SATSA), a
longitudinal cohort of older individuals in their 70s.
DNA methylation outlier burden
There was high variability in DNA methylation outlier
number between individuals. DNA methylation outlier
burden was highly positively skewed and consequently
a log10-transformed version of outlier burden used in
all analyses. This is consistent with previous findings
[13, 14].
Fig. 3 DNA methylation outlier burden survival plot in the LBC1921 and the LBC1936. Survival probability by top and bottom quartile of log10(outlier
burden) adjusted for sex and chronological age in the LBC1921 and in the LBC1936
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When looking at outlier burden per CpG site rather
than per individual, Wang and colleagues [13] reported
that at 64% of CpG sites, at least one out of 385 individ-
uals in SATSA had an outlier. Here, we found a similar
number of CpG sites (63%) that were an outlier in at
least one out of the 430 individuals in the LBC1921.
However, our findings demonstrate that with increasing
sample size, almost all sites will be an outlier at least
once (83% of CpG sites in 898 individuals in the
LBC1936 and > 96% in 7010 individuals in Generation
Scotland). This may suggest that the accumulation of
DNA methylation outliers with age is a stochastic
process, affecting most CpG sites randomly. However,
we observed differences in the distribution of outliers
across open seas and CpG islands, consistent with previ-
ous reports [13].
DNA methylation outlier burden and age
DNA methylation outlier burden was found to be posi-
tively associated with age in Generation Scotland and in
the Lothian Birth Cohorts. The association between age
and log10(outlier burden) was significant in Generation
Scotland independent of the level of adjustment and in
the LBC1921 after adjustments for cell counts. A similar
association was seen in the LBC1936 although it was not
significant. Effect sizes were comparable to those re-
ported by Wang and colleagues (β = 8.3 × 10−3, p = 1.2
× 10−13 [13]).
DNA methylation outlier burden measures were
strongly associated with cell proportions and other tech-
nical factors, again, confirming previous findings [13,
14]. Moreover, in this study, batch effects were con-
founded by wave of data collection in the LBC1921 and
LBC1936. Outliers were thus defined as values ± 3 inter-
quartile ranges from the upper/lower quartile in each
wave rather than at baseline, in order to reduce this con-
founding effect and obtain more stable definitions.
There was no difference in DNA methylation outlier
burden between men and women in any of the three co-
horts. This is consistent with findings reported by Curtis
and colleagues [14] but not with those by Wang and col-
leagues [13] who found women to have a slightly higher
outlier burden than men. To minimise confounding by
sex, Wang and colleagues consequently defined outliers
according to methylation level variability in women and
men separately.
DNA methylation outlier burden and epigenetic drift
We hypothesised that rather than merely being a conse-
quence of an increase in outlier burden with age, the
age-related increase in DNA methylation variability (epi-
genetic drift) may in fact contribute to the identification
of larger numbers of outliers. An older individual’s
methylation level might be classified as an outlier when
compared to methylation levels in the entire sample, but
it may not when compared to that of other older indi-
viduals (amongst whom variability is higher) (Supple-
mentary Figure 5, Additional file 2).
Here, we found that controlling for epigenetic drift, by
defining outliers based on variability in age deciles, only
slightly attenuated the association between DNA methy-
lation outlier burden and age in Generation Scotland.
Of course, defining outliers in even narrower age
ranges could have further attenuated the association be-
tween outlier burden and age. However, there also was
an association between outlier burden and age in the
Lothian Birth Cohorts, despite outliers being defined
within waves of data collection with very narrow age
ranges. Taken together, these findings suggest that the
age-related increase in extreme methylation levels (that
is, epigenetic outliers) and the age-related increase in
methylation level variability (epigenetic drift) appear to
be, at least in part, two separate phenomena.
This is also consistent with findings by Wang and col-
leagues [13] who demonstrated that CpG sites where
DNA methylation outliers occur frequently do not tend
to be the same CpG sites where methylation level vari-
ability increases with age. Of 1185 CpG sites with out-
liers in more than 50 individuals, only two had
previously been identified as being variably methylated.
DNA methylation outlier burden, health, and survival
In contrast to previous studies, we did not find DNA
methylation outlier burden to be associated with self-
reported or family history of cancer [7, 13]. Furthermore,
it was not associated with a comprehensive list of other
self-reported disease outcomes. The prevalence of self-
reported disease outcomes in Generation Scotland was
variable, ranging from five cases of Alzheimer’s disease
to 1065 cases of hypertension. It is possible that for sev-
eral disease outcomes, there was insufficient statistical
power to detect associations with DNA methylation out-
lier burden due to limited observations. While other
work has linked extreme DNA methylation patterns to
congenital abnormalities [9] and low birth weight [18],
the findings of the present study do not support strong
links between DNA methylation outlier burden and age-
related health outcomes.
In addition, we found mixed evidence regarding the
association of DNA methylation outlier burden and life-
style variables. DNA methylation outlier burden has pre-
viously been linked to smoking [19] but not to BMI [12,
19]. In Generation Scotland, higher DNA methylation
outlier burden was found to be significantly positively
associated with smoking pack-years and significantly
negatively associated with BMI. There were no signifi-
cant associations between these variables in the
LBC1921 and LBC1936.
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While there was a positive correlation between DNA
methylation outlier burden and GrimAge acceleration,
an established predictor of mortality, there was no sig-
nificant association between higher outlier burden and a
higher risk of mortality in the LBC cohorts after correc-
tion for multiple testing.
Heritability of DNA methylation outlier burden
Consistent with findings in twins by Wang and col-
leagues [13], there was no evidence that outlier burden
is heritable.
Strengths and limitations
Here, we provide a comprehensive characterisation of
DNA methylation outlier burden in three large inde-
pendent cohorts. The sample size of the Generation
Scotland cohort is an order of magnitude greater than
previous studies [12–14]. In addition, this is the first
study to systematically relate DNA methylation outlier
burden to a range of diseases and to survival.
There are limitations to this study. First, the distribu-
tion of log10(outlier burden) in Generation Scotland was
still slightly positively skewed after log10 transformation
and its association with age was thus non-linear. Disease
status, including cancer information, in the Generation
Scotland study was measured by self-report which can
be unreliable. In addition, this data was cross-sectional,
and for some diseases, prevalence rates were low (e.g.
Alzheimer’s disease and Parkinson’s disease; Supplemen-
tary Tables 6 and 7, Additional file 1) which may have
limited the present study’s ability to detect significant
associations. Finally, we did not run analyses separately
on outliers based on their direction, that is, ‘high’ out-
liers with abnormally high methylation levels and ‘low’
outliers with lower than average methylation levels [13].
We also did not investigate the functional pathways in
which outliers may cluster (some work on this reported
in [13, 14, 19]).
Conclusions
The findings of our study are consistent with previous
work, demonstrating an increase in the number of DNA
methylation outliers in individuals as they age. This sug-
gests that DNA methylation outliers are unlikely to be
just technical artefacts. Furthermore, our findings show
that the accumulation of DNA methylation outliers with
age is unlikely to be an artefact of epigenetic drift and
that it does indeed appear to be driven by stochastic
processes. We also demonstrate that the measurement
of DNA methylation outliers is heavily associated with
cell counts and technical factors. We do not find DNA
methylation outlier burden to be robustly associated
with age-related diseases, and future studies in larger
samples are needed to confirm whether it can predict
survival. Based on the findings reported here, DNA
methylation outlier burden may be useful as a marker of
biological age and predict survival, but more work will
be needed to establish whether DNA methylation out-
liers can offer insights into the associations between age-
ing, health, and lifestyle.
Methods
Here, we used data from the cross-sectional Generation
Scotland cohort, as well as from the longitudinal Lothian
Birth Cohorts of 1921 and 1936.
The Generation Scotland cohort
Generation Scotland is a family-based cohort consisting of
individuals aged 18 to 98 years, living across Scotland.
Participants were initially recruited from individuals regis-
tered at GP surgeries and then asked to invite first degree
relatives to join the study, resulting in a final sample size
of 23,960 individuals. For these participants, genetic as
well as clinical, lifestyle, and sociodemographic informa-
tion are available. Further details on the cohort can be
found elsewhere [20, 21].
The Generation Scotland Scottish Family Health Study
has been ethically approved and granted research tissue
bank status by the NHS East of Scotland Research Ethics
Service (REC reference numbers: 05/S1401/89 and 15/
ES/0040, respectively). All study participants provided
informed written consent.
The Lothian Birth Cohorts of 1921 and 1936
The Lothian Birth Cohorts are two longitudinal cohort
studies of ageing in individuals born in 1921 (LBC1921,
n = 550) or in 1936 (LBC1936, n = 1091). At age 11, as
part of the Scottish Mental Health Surveys of 1932 and
1947, respectively, most of these individuals completed
the Moray House Test of general intelligence. Decades
later, those living in Edinburgh and the surrounding
Lothian region were re-contacted and invited to partici-
pate in the Lothian Birth Cohort studies. Recruitment
and baseline testing (wave 1) took place between 1999
and 2001 (mean age ~ 79), and between 2004 and 2007
(mean age ~ 70) for the LBC1921 and LBC1936, respect-
ively. Since then, detailed physical, cognitive, psycho-
social, and lifestyle information was collected roughly
every 3 years in 4 subsequent waves of testing. In
addition, genetic and longitudinal epigenetic profiling is
available in both the LBC1921 and the LBC1936. More
detail on recruitment and testing can be found elsewhere
[22, 23].
Ethical approval for the first wave of Lothian Birth
Cohort studies was obtained from the Multi-Centre Re-
search Ethics Committee for Scotland (MREC/01/0/56)
and the Lothian Research Ethics committee (LREC/
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1998/4/183; LREC/2003/2/29). All participants provided
written informed consent.
DNA methylation data
Genome-wide DNA methylation in Generation Scotland
was measured from blood samples collected between 2006
and 2011 (at the time of baseline appointment) using the
Illumina Infinium HumanMethylationEPIC BeadChip at >
850,000 CpG sites. The methylation profiling was carried
out in two sets, here referred to as set 1 and set 2. Set 1
consisted of 5200 individuals (2586 of whom were genetic-
ally unrelated to each other at a relatedness threshold of <
0.025); set 2 consisted of a further 4683 unrelated individ-
uals—both to others in set 2 and all of those in set 1.
Methylation profiling in set 1 and set 2 was carried out in
31 batches each. Full details of DNA methylation quality
control steps can be found in Additional file 2 (Supple-
mentary Note 1, Additional file 2).
DNA methylation in the Lothian Birth Cohorts was
measured repeatedly using the Illumina HumanMethyla-
tion450K array at > 450,000 CpG sites. Methylation data
are available in three waves in LBC1921 (wave 1, 3, and
4) and in four waves in LBC1936 (wave 1, 2, 3, and 4).
Samples in LBC1936 were processed in three separate
batches (Supplementary Table 11, Additional file 1) on
13 dates, using 41 plates and 309 microarrays in total.
All samples in LBC1921 were processed in one batch on
7 dates, using 11 plates and 76 microarrays. Sample col-
lection and quality control steps have been described in
greater detail elsewhere [24, 25]. For a brief description,
see Supplementary Note 1, Additional file 2.
Following quality control, methylation β-values were
calculated using the m2beta function in lumi [26]. Probes
targeting polymorphic sites in the European population,
ch-probes, and probes predicted to hybridise to multiple
genomic regions (identified for the EPIC array by McCart-
ney et al.) were removed [27]. In addition, probes on the
X and Y chromosomes and probes with known meQTLs
were excluded. Note that the meQTL probes (both cis and
trans) were identified using the Illumina Infinium
HumanMethylation450 array [28] and that no compre-
hensive list is currently available for the EPIC array.
Following post-QC filtering, the datasets comprised
the following sites and samples: 356,631 sites in 436
samples in the LBC1921 and in 906 samples in the
LBC1936; 678,519 sites in 2586 unrelated individuals in
Generation Scotland set 1; and 724,207 sites in 4450 in-
dividuals in Generation Scotland set 2. Here, we limit
our analyses to the 334,352 and 349,027 sites measured
in Generation Scotland set 1 and set 2, respectively,
which are also present on the HumanMethylation450
array. This will make results from Generation Scotland
more comparable to those obtained in the Lothian Birth
Cohorts.
Covariates
In addition to technical factors (batch and set in Gener-
ation Scotland; date, plate, and array in the Lothian Birth
Cohorts), a number of phenotypes were included as co-
variates in the analyses. These included white blood cell
proportions of granulocytes, natural killer (NK) cells, B
cells, CD4+T cells, and CD8+T cells which had been esti-
mated from DNA methylation using the Houseman
method [29] as implemented in the estimateCellCounts
function in minfi [30]. Furthermore, a binary ever-never
smoking variable, a log10-transformed continuous smok-
ing pack years variable, a binary self-report cancer diag-
nosis (yes/no) variable, and a log10-transformed
continuous measure of body mass index (BMI) were in-
cluded as covariates. Variables were log10-transformed in
order to minimise positive skew. Full details can be
found in Supplementary Notes 1 and 2, Additional file 2.
Health and survival data
In Generation Scotland, DNA methylation outlier bur-
den was related to more than a dozen binary mea-
sures of self-reported disease and self-reported family
history of disease. In the Lothian Birth Cohorts, DNA
methylation outlier burden was related to survival.
Mortality data was provided by the General Register
Office for Scotland (National Records Scotland)
through data linkage to the National Health Service
Central Register. The data used in the analyses re-
ported here are correct as of January 2018 (LBC1921)
and April 2018 (LBC1936). At time of last censor (ap-
proximately 18 years from baseline for the LBC1921
and approximately 14 years from baseline for the
LBC1936), 37 and 680 participants of the LBC1921
and LBC1936 were alive, respectively.
DNA methylation outlier burden
In Generation Scotland, DNA methylation outliers
were defined as per Gentilini and colleagues [12], that
is, as sites with methylation levels greater than three
times the interquartile range (IQR) from the upper or
lower quartile. Outliers were calculated within each
set separately. Data from Generation Scotland set 1
and set 2 were then combined for all following ana-
lyses. In the longitudinal Lothian Birth Cohort stud-
ies, DNA methylation outliers were calculated in each
wave of data collection based on the IQR calculated
in that wave (rather than the IQR in wave 1, as done
by Wang and colleagues [13]). The reason for this is
that there are strong technical effects on DNA methy-
lation measures and that in the Lothian Birth Co-
horts, technical factors are confounded by wave of
sample collection. For instance, processing set is con-
founded by wave of sample collection in the LBC1936
(Supplementary Table 11, Additional file 1). In
Seeboth et al. Clinical Epigenetics           (2020) 12:49 Page 9 of 13
addition, factors such as plate and date are con-
founded by wave even within processing sets. By de-
fining outliers within each wave, we hoped to
minimise these batch effects, resulting in more stable
outlier definitions. Finally, outlier burden per individ-
ual was calculated as the total number of outlier sites
for each individual. In addition, outliers per CpG site
were calculated as the total number of individuals
with an outlier per site. Following this, samples with
extreme values for any of the estimated cell propor-
tions (> 5 standard deviations from the mean) were
removed (5 and 13 samples in Generation Scotland
set 1 and set 2, and 7 and 32 samples in LBC1921
and LBC1936, respectively). In addition, a further
eight individuals from Generation Scotland set 1 were
excluded from the analyses because they had
responded with ‘yes’ to every self-reported disease
phenotype included on the questionnaire.
A combined dataset of 7010 individuals remained for
analysis in Generation Scotland (2573 in set 1 and 4437
in set 2). The final Lothian Birth Cohort samples con-
sisted of 430 individuals (685 measurements) in the
LBC1921 and 898 individuals (2801 measurements) in
the LBC1936.
Analyses
All analyses were performed in R [31]. The lme4 [32],
lmerTest [33], and survival [34] packages were used to
construct linear mixed models and Cox regression
models. The ggplot2 [35] and survminer [36] packages
were used to create graphs. For a flowchart displaying
the analysis steps, see Fig. 4.
DNA methylation outlier burden and age
Cross-sectional associations between a log10-transformed
version of DNA methylation outlier burden and age in
Generation Scotland were obtained by fitting three linear
models. The basic model included sex as a covariate. The
second model included additional adjustments for esti-
mated white blood cell proportions (granulocytes, natural
killer (NK) cells, B cells, CD4+T cells, and CD8+T cells)
and technical variables (batch and set). The third (fully ad-
justed) model also controlled for smoking (ever/never),
log10(pack years + 1), cancer diagnosis (yes/no), and
Fig. 4 Flowchart of analyses in the Generation Scotland and Lothian Birth Cohorts. Methylation profiling in Generation Scotland was carried out
in two separate sets. DNA methylation outliers were calculated within each set. Analyses were then carried out on a combined dataset. In the
Lothian Birth Cohorts of 1921 and 1936, DNA methylation outliers were calculated within each wave of data collection. Analyses were carried out
in the LBC1921 and the LBC1936 separately. Results from the survival analyses in both cohorts were meta-analysed
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log10(BMI). The first model was a linear regression,
whereas models 2 and 3 were linear mixed effects models
with a random intercept term fitted for batch.
Longitudinal analyses of outlier burden in the Lothian
Birth Cohorts were run by fitting the following three linear
mixed models with random intercepts for ID and batch vari-
ables. The most basic model included sex as a fixed effect.
The adjusted model included sex, estimated white blood cell
proportions (granulocytes, natural killer (NK) cells, B cells,
CD4+T cells, and CD8+T cells), and technical factors (date,
plate, and array) with final adjustments made for smoking
(ever/never), log10(pack years + 1), cancer diagnosis (yes/no),
and log10(BMI).
Measures of epigenetic age acceleration for each cohort
were obtained from the DNA methylation age calculator
(https://dnamage.genetics.ucla.edu/). The relationship be-
tween outlier burden and intrinsic epigenetic age acceler-
ation, Hannum age acceleration, and GrimAge acceleration
was assessed using linear models [15–17].
DNA methylation outlier burden and epigenetic drift
Variability in methylation levels is known to increase
over time (epigenetic drift) [5, 6]. In order to investigate
whether this affects the association between outlier bur-
den and age, we re-calculated outliers in Generation
Scotland in an alternative fashion. We defined outliers
as extreme methylation levels with respect to variability
between individuals of the same age group rather than
variability overall (Supplementary Figure 5, Additional
file 2). We defined outliers as methylation levels greater
than three times the IQR above or below the upper and
lower quartile based on the variability within age deciles.
DNA methylation outlier burden, health, and survival
Logistic regression models with basic adjustments for age
and sex, followed by full adjustment for cell count propor-
tions, smoking status and log(pack years), cancer, and
log(BMI) were fit to investigate the association between
DNA methylation outlier burden and binary measures of
self-reported disease in the large Generation Scotland
dataset. As prevalence rates for some diseases were low,
analyses were repeated using self-reports of family history
(in mother or father) of disease. We corrected for multiple
testing using Bonferroni correction (p < 0.05/13 = 3.9 ×
10−3 for self-reported disease and p < 0.05/16 = 3.1 × 10−3
for self-reported family history of disease).
Multivariate Cox proportional hazards models with
two levels of adjustments (as per the logistic models de-
scribed above) were fit to study the association between
survival and outlier burden at baseline in the Lothian
Birth Cohorts of 1921 and 1936.
A meta-analysis of hazard ratios obtained in the
LBC1921 and the LBC1936 was run using a fixed effect
model as implemented in the rma.uni function in the
metafor package [37]. We corrected for multiple testing
using Bonferroni correction (p < 0.05/3 = 0.017).
Identification of outlier individuals
Outlier individuals were defined as those with an outlier
burden ± 3 interquartile ranges from the upper/lower
quartile of the outlier burden in each cohort.
Heritability of DNA methylation outlier burden
Genotype data at > 700,000 SNPs in Generation Scotland
was generated using the Illumina OMNIExpress chip.
Briefly, SNPs with more than 2% missingness and a
Hardy-Weinberg equilibrium test p < 10−6 were excluded
during quality control. This has been described in greater
detail elsewhere [38]. The genetic contribution by all
genome-wide SNPs to phenotypic variance in log10(outlier
burden) was estimated using genome-wide complex trait
analysis (GCTA), GCTA-GREML [39].
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